Antegrade/Retrograde Cardioplegia Valve Systems
510(k) K922840
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK922840 | Date17 May 1993 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTL
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.4290
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 6 Oct 2026
An Antegrade/Retrograde Cardioplegia Valve System is a cardiovascular device classified as an adaptor, stopcock, manifold, fitting, and cardiopulmonary bypass component. It is designed for use in cardioplegia delivery during cardiac surgery, allowing both antegrade and retrograde administration of cardioplegic solution and blood.
The system is supplied as a reusable device and requires cleaning and sterilization between uses. It is indicated for use in cardiovascular surgical settings and is subject to special controls under FDA 510(k) clearance K922840, with product code DTL and device class II.
Other devices from Gish Biomedical, Inc.
Questions
AI-generated answers, 6 Oct 2026
What is the Antegrade/Retrograde Cardioplegia Valve System used for?
The Antegrade/Retrograde Cardioplegia Valve System is designed for use in cardioplegia delivery during cardiac surgery, allowing both antegrade and retrograde administration of cardioplegic solution and blood to protect the heart muscle during procedures requiring cardiopulmonary bypass.
Is the Antegrade/Retrograde Cardioplegia Valve System reusable or single-use?
The system is supplied as a reusable device and requires cleaning and sterilization between uses, as stated in the device description, to ensure safe repeated application in cardiovascular surgical settings.
What regulatory pathway was used for the Antegrade/Retrograde Cardioplegia Valve System?
The device received FDA 510(k) clearance under K922840, classified as substantially equivalent to a predicate device, and is subject to special controls for its device class II classification under product code DTL.